Trials

CTD Holdings Clinical Trial

CTD Holding’s Trappsol Cyclodextrin trial is currently enrolling in two trial sites: Oakland, US and Manchester, UK.  The Phase 1 trial in the US requires patients to be 18+ and is looking to recruit approximately 12 patients for a research study lasting up to 20 weeks.   The Phase 1/2 trial in the UK is also looking…

Read More